HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company transforming ...

Detailed price information for Heart Test Laboratories WT (HSCSW-Q) from The Globe and Mail including charting and trades.

SEC Hits Mississippi State With Massive Fine After Arizona State Upset Macron’s government collapses: What comes next? A Massive New Study Says This Is What Happens to People Who Drink Black Coffee ...

A minimalist approach to transcatheter aortic valve implantation (TAVI), without sedation, was noninferior to the standard approach for the primary outcome at 30 days, according to late-breaking ...

A 74-year-old man presents to the emergency department with a 1-day history of severe chest and back pain. He has a history of hypertension and has run out of medication. He has no history of similar ...

ABBOTT PARK, Ill., Aug. 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for an expanded indication for the company's Navitor™ transcatheter aortic valve ...

Background: Transcatheter aortic valve replacement (TAVR) is increasingly performed in younger, low surgical risk patients. This NOTION-2 study reports mid-term outcomes in low-risk patients aged ...

At the annual meeting of the European Society of Cardiology (ESC), being held this weekend in Madrid, new cardiac care guidelines call for a more uniform, simplified and accessible approach to ...

Abbott (NYSE: ABT) + announced today that it received CE mark for an expanded indication for its Navitor TAVI system. The expanded indication enables treatment for symptomatic severe aortic stenosis ...

Patients with severe aortic stenosis (AS) who are managed medically have a poor prognosis. No contemporary studies have examined resource use and costs associated with medical management for severe AS ...